nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—Zopiclone—CYP2E1—liver cancer	0.0154	1	CrCbGaD
Eszopiclone—CYP2C8—Sorafenib—liver cancer	0.015	0.426	CbGbCtD
Eszopiclone—CYP2C9—Sorafenib—liver cancer	0.0105	0.297	CbGbCtD
Eszopiclone—CYP3A4—Sorafenib—liver cancer	0.00608	0.173	CbGbCtD
Eszopiclone—CYP3A4—Doxorubicin—liver cancer	0.00369	0.105	CbGbCtD
Eszopiclone—Salivary hypersecretion—Epirubicin—liver cancer	0.00204	0.00327	CcSEcCtD
Eszopiclone—Cystitis—Epirubicin—liver cancer	0.00203	0.00325	CcSEcCtD
Eszopiclone—Anaphylactic shock—Sorafenib—liver cancer	0.00203	0.00325	CcSEcCtD
Eszopiclone—Colitis—Epirubicin—liver cancer	0.00202	0.00324	CcSEcCtD
Eszopiclone—Infection—Sorafenib—liver cancer	0.00201	0.00323	CcSEcCtD
Eszopiclone—Gait disturbance—Doxorubicin—liver cancer	0.00199	0.0032	CcSEcCtD
Eszopiclone—Vaginal infection—Epirubicin—liver cancer	0.00198	0.00318	CcSEcCtD
Eszopiclone—Coordination abnormal—Doxorubicin—liver cancer	0.00198	0.00318	CcSEcCtD
Eszopiclone—Neuropathy—Epirubicin—liver cancer	0.00197	0.00316	CcSEcCtD
Eszopiclone—Hepatocellular injury—Doxorubicin—liver cancer	0.00194	0.00312	CcSEcCtD
Eszopiclone—Hiccups—Doxorubicin—liver cancer	0.00194	0.00312	CcSEcCtD
Eszopiclone—Vaginal inflammation—Doxorubicin—liver cancer	0.00194	0.00312	CcSEcCtD
Eszopiclone—Dry eye—Epirubicin—liver cancer	0.00194	0.00311	CcSEcCtD
Eszopiclone—Anorexia—Sorafenib—liver cancer	0.00193	0.0031	CcSEcCtD
Eszopiclone—Cramps of lower extremities—Epirubicin—liver cancer	0.00193	0.0031	CcSEcCtD
Eszopiclone—Dermatitis contact—Doxorubicin—liver cancer	0.00192	0.00308	CcSEcCtD
Eszopiclone—Abnormal dreams—Doxorubicin—liver cancer	0.00192	0.00308	CcSEcCtD
Eszopiclone—Rash maculo-papular—Epirubicin—liver cancer	0.00191	0.00306	CcSEcCtD
Eszopiclone—Bladder pain—Epirubicin—liver cancer	0.0019	0.00305	CcSEcCtD
Eszopiclone—Mouth ulceration—Epirubicin—liver cancer	0.0019	0.00305	CcSEcCtD
Eszopiclone—Melaena—Doxorubicin—liver cancer	0.0019	0.00305	CcSEcCtD
Eszopiclone—Cystitis noninfective—Doxorubicin—liver cancer	0.0019	0.00305	CcSEcCtD
Eszopiclone—Salivary hypersecretion—Doxorubicin—liver cancer	0.00189	0.00303	CcSEcCtD
Eszopiclone—Cystitis—Doxorubicin—liver cancer	0.00188	0.00301	CcSEcCtD
Eszopiclone—Colitis—Doxorubicin—liver cancer	0.00187	0.00299	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00185	0.00296	CcSEcCtD
Eszopiclone—Hypertonia—Epirubicin—liver cancer	0.00184	0.00295	CcSEcCtD
Eszopiclone—Vaginal infection—Doxorubicin—liver cancer	0.00184	0.00294	CcSEcCtD
Eszopiclone—Neuropathy—Doxorubicin—liver cancer	0.00183	0.00293	CcSEcCtD
Eszopiclone—Mental disability—Epirubicin—liver cancer	0.00182	0.00292	CcSEcCtD
Eszopiclone—Dyspnoea—Sorafenib—liver cancer	0.00181	0.0029	CcSEcCtD
Eszopiclone—Dry eye—Doxorubicin—liver cancer	0.0018	0.00288	CcSEcCtD
Eszopiclone—Lymphadenopathy—Epirubicin—liver cancer	0.00179	0.00287	CcSEcCtD
Eszopiclone—Cramps of lower extremities—Doxorubicin—liver cancer	0.00179	0.00286	CcSEcCtD
Eszopiclone—Dyspepsia—Sorafenib—liver cancer	0.00179	0.00286	CcSEcCtD
Eszopiclone—Rash maculo-papular—Doxorubicin—liver cancer	0.00177	0.00283	CcSEcCtD
Eszopiclone—Decreased appetite—Sorafenib—liver cancer	0.00176	0.00283	CcSEcCtD
Eszopiclone—Thrombophlebitis—Epirubicin—liver cancer	0.00176	0.00283	CcSEcCtD
Eszopiclone—Mouth ulceration—Doxorubicin—liver cancer	0.00176	0.00282	CcSEcCtD
Eszopiclone—Bladder pain—Doxorubicin—liver cancer	0.00176	0.00282	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Sorafenib—liver cancer	0.00175	0.00281	CcSEcCtD
Eszopiclone—Fatigue—Sorafenib—liver cancer	0.00175	0.00281	CcSEcCtD
Eszopiclone—Photosensitivity—Epirubicin—liver cancer	0.00174	0.00279	CcSEcCtD
Eszopiclone—Pain—Sorafenib—liver cancer	0.00173	0.00278	CcSEcCtD
Eszopiclone—Constipation—Sorafenib—liver cancer	0.00173	0.00278	CcSEcCtD
Eszopiclone—Hypertonia—Doxorubicin—liver cancer	0.0017	0.00273	CcSEcCtD
Eszopiclone—Eczema—Epirubicin—liver cancer	0.0017	0.00272	CcSEcCtD
Eszopiclone—Mental disability—Doxorubicin—liver cancer	0.00169	0.00271	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Sorafenib—liver cancer	0.00166	0.00266	CcSEcCtD
Eszopiclone—Lymphadenopathy—Doxorubicin—liver cancer	0.00165	0.00265	CcSEcCtD
Eszopiclone—Thrombophlebitis—Doxorubicin—liver cancer	0.00163	0.00262	CcSEcCtD
Eszopiclone—Increased appetite—Epirubicin—liver cancer	0.00162	0.0026	CcSEcCtD
Eszopiclone—Urticaria—Sorafenib—liver cancer	0.00161	0.00258	CcSEcCtD
Eszopiclone—Photosensitivity—Doxorubicin—liver cancer	0.00161	0.00258	CcSEcCtD
Eszopiclone—Abdominal pain—Sorafenib—liver cancer	0.0016	0.00257	CcSEcCtD
Eszopiclone—Body temperature increased—Sorafenib—liver cancer	0.0016	0.00257	CcSEcCtD
Eszopiclone—Dermatitis bullous—Epirubicin—liver cancer	0.0016	0.00256	CcSEcCtD
Eszopiclone—Eczema—Doxorubicin—liver cancer	0.00157	0.00252	CcSEcCtD
Eszopiclone—Diplopia—Epirubicin—liver cancer	0.00153	0.00245	CcSEcCtD
Eszopiclone—Osteoarthritis—Epirubicin—liver cancer	0.00153	0.00245	CcSEcCtD
Eszopiclone—Increased appetite—Doxorubicin—liver cancer	0.0015	0.00241	CcSEcCtD
Eszopiclone—Migraine—Epirubicin—liver cancer	0.0015	0.00241	CcSEcCtD
Eszopiclone—Affect lability—Epirubicin—liver cancer	0.0015	0.00241	CcSEcCtD
Eszopiclone—Hypersensitivity—Sorafenib—liver cancer	0.00149	0.0024	CcSEcCtD
Eszopiclone—Dermatitis bullous—Doxorubicin—liver cancer	0.00148	0.00237	CcSEcCtD
Eszopiclone—Face oedema—Epirubicin—liver cancer	0.00147	0.00236	CcSEcCtD
Eszopiclone—Asthenia—Sorafenib—liver cancer	0.00146	0.00233	CcSEcCtD
Eszopiclone—Mood swings—Epirubicin—liver cancer	0.00144	0.00232	CcSEcCtD
Eszopiclone—Pruritus—Sorafenib—liver cancer	0.00143	0.0023	CcSEcCtD
Eszopiclone—Ataxia—Epirubicin—liver cancer	0.00143	0.0023	CcSEcCtD
Eszopiclone—Dehydration—Epirubicin—liver cancer	0.00142	0.00228	CcSEcCtD
Eszopiclone—Diplopia—Doxorubicin—liver cancer	0.00141	0.00226	CcSEcCtD
Eszopiclone—Osteoarthritis—Doxorubicin—liver cancer	0.00141	0.00226	CcSEcCtD
Eszopiclone—Dry skin—Epirubicin—liver cancer	0.0014	0.00224	CcSEcCtD
Eszopiclone—Migraine—Doxorubicin—liver cancer	0.00139	0.00223	CcSEcCtD
Eszopiclone—Affect lability—Doxorubicin—liver cancer	0.00139	0.00223	CcSEcCtD
Eszopiclone—Hypokalaemia—Epirubicin—liver cancer	0.00139	0.00223	CcSEcCtD
Eszopiclone—Diarrhoea—Sorafenib—liver cancer	0.00139	0.00223	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00137	0.0022	CcSEcCtD
Eszopiclone—Face oedema—Doxorubicin—liver cancer	0.00136	0.00219	CcSEcCtD
Eszopiclone—Gastritis—Epirubicin—liver cancer	0.00135	0.00217	CcSEcCtD
Eszopiclone—Muscular weakness—Epirubicin—liver cancer	0.00135	0.00216	CcSEcCtD
Eszopiclone—Dizziness—Sorafenib—liver cancer	0.00134	0.00215	CcSEcCtD
Eszopiclone—Mood swings—Doxorubicin—liver cancer	0.00134	0.00214	CcSEcCtD
Eszopiclone—Ataxia—Doxorubicin—liver cancer	0.00133	0.00213	CcSEcCtD
Eszopiclone—Asthma—Epirubicin—liver cancer	0.00132	0.00211	CcSEcCtD
Eszopiclone—Dysphagia—Epirubicin—liver cancer	0.00132	0.00211	CcSEcCtD
Eszopiclone—Influenza—Epirubicin—liver cancer	0.00132	0.00211	CcSEcCtD
Eszopiclone—Dehydration—Doxorubicin—liver cancer	0.00131	0.00211	CcSEcCtD
Eszopiclone—Dry skin—Doxorubicin—liver cancer	0.00129	0.00208	CcSEcCtD
Eszopiclone—Vomiting—Sorafenib—liver cancer	0.00129	0.00207	CcSEcCtD
Eszopiclone—Hypokalaemia—Doxorubicin—liver cancer	0.00128	0.00206	CcSEcCtD
Eszopiclone—Rash—Sorafenib—liver cancer	0.00128	0.00205	CcSEcCtD
Eszopiclone—Dermatitis—Sorafenib—liver cancer	0.00128	0.00205	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00127	0.00204	CcSEcCtD
Eszopiclone—Headache—Sorafenib—liver cancer	0.00127	0.00204	CcSEcCtD
Eszopiclone—Bronchitis—Epirubicin—liver cancer	0.00127	0.00203	CcSEcCtD
Eszopiclone—Gastritis—Doxorubicin—liver cancer	0.00125	0.002	CcSEcCtD
Eszopiclone—Muscular weakness—Doxorubicin—liver cancer	0.00124	0.002	CcSEcCtD
Eszopiclone—Dysuria—Epirubicin—liver cancer	0.00123	0.00198	CcSEcCtD
Eszopiclone—Asthma—Doxorubicin—liver cancer	0.00122	0.00196	CcSEcCtD
Eszopiclone—Influenza—Doxorubicin—liver cancer	0.00122	0.00196	CcSEcCtD
Eszopiclone—Dysphagia—Doxorubicin—liver cancer	0.00122	0.00196	CcSEcCtD
Eszopiclone—Pollakiuria—Epirubicin—liver cancer	0.00122	0.00195	CcSEcCtD
Eszopiclone—Nausea—Sorafenib—liver cancer	0.0012	0.00193	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Epirubicin—liver cancer	0.0012	0.00193	CcSEcCtD
Eszopiclone—Weight increased—Epirubicin—liver cancer	0.0012	0.00192	CcSEcCtD
Eszopiclone—Weight decreased—Epirubicin—liver cancer	0.00119	0.00191	CcSEcCtD
Eszopiclone—Drowsiness—Epirubicin—liver cancer	0.00118	0.00189	CcSEcCtD
Eszopiclone—Bronchitis—Doxorubicin—liver cancer	0.00117	0.00188	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Epirubicin—liver cancer	0.00115	0.00185	CcSEcCtD
Eszopiclone—Stomatitis—Epirubicin—liver cancer	0.00115	0.00184	CcSEcCtD
Eszopiclone—Urinary tract infection—Epirubicin—liver cancer	0.00114	0.00183	CcSEcCtD
Eszopiclone—Conjunctivitis—Epirubicin—liver cancer	0.00114	0.00183	CcSEcCtD
Eszopiclone—Dysuria—Doxorubicin—liver cancer	0.00114	0.00183	CcSEcCtD
Eszopiclone—Sweating—Epirubicin—liver cancer	0.00113	0.00181	CcSEcCtD
Eszopiclone—Pollakiuria—Doxorubicin—liver cancer	0.00113	0.00181	CcSEcCtD
Eszopiclone—Haematuria—Epirubicin—liver cancer	0.00112	0.0018	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Doxorubicin—liver cancer	0.00111	0.00179	CcSEcCtD
Eszopiclone—Weight increased—Doxorubicin—liver cancer	0.00111	0.00178	CcSEcCtD
Eszopiclone—Epistaxis—Epirubicin—liver cancer	0.00111	0.00178	CcSEcCtD
Eszopiclone—Weight decreased—Doxorubicin—liver cancer	0.0011	0.00177	CcSEcCtD
Eszopiclone—Drowsiness—Doxorubicin—liver cancer	0.00109	0.00174	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Doxorubicin—liver cancer	0.00107	0.00171	CcSEcCtD
Eszopiclone—Stomatitis—Doxorubicin—liver cancer	0.00106	0.0017	CcSEcCtD
Eszopiclone—Rhinitis—Epirubicin—liver cancer	0.00106	0.0017	CcSEcCtD
Eszopiclone—Urinary tract infection—Doxorubicin—liver cancer	0.00106	0.0017	CcSEcCtD
Eszopiclone—Conjunctivitis—Doxorubicin—liver cancer	0.00106	0.0017	CcSEcCtD
Eszopiclone—Hepatitis—Epirubicin—liver cancer	0.00105	0.00169	CcSEcCtD
Eszopiclone—Hypoaesthesia—Epirubicin—liver cancer	0.00105	0.00168	CcSEcCtD
Eszopiclone—Pharyngitis—Epirubicin—liver cancer	0.00105	0.00168	CcSEcCtD
Eszopiclone—Sweating—Doxorubicin—liver cancer	0.00104	0.00167	CcSEcCtD
Eszopiclone—Oedema peripheral—Epirubicin—liver cancer	0.00104	0.00167	CcSEcCtD
Eszopiclone—Haematuria—Doxorubicin—liver cancer	0.00104	0.00166	CcSEcCtD
Eszopiclone—Epistaxis—Doxorubicin—liver cancer	0.00103	0.00165	CcSEcCtD
Eszopiclone—Erythema multiforme—Epirubicin—liver cancer	0.000998	0.0016	CcSEcCtD
Eszopiclone—Tinnitus—Epirubicin—liver cancer	0.000984	0.00158	CcSEcCtD
Eszopiclone—Rhinitis—Doxorubicin—liver cancer	0.000979	0.00157	CcSEcCtD
Eszopiclone—Hepatitis—Doxorubicin—liver cancer	0.000976	0.00157	CcSEcCtD
Eszopiclone—Hypoaesthesia—Doxorubicin—liver cancer	0.000971	0.00156	CcSEcCtD
Eszopiclone—Pharyngitis—Doxorubicin—liver cancer	0.000969	0.00155	CcSEcCtD
Eszopiclone—Oedema peripheral—Doxorubicin—liver cancer	0.000962	0.00154	CcSEcCtD
Eszopiclone—Chills—Epirubicin—liver cancer	0.000947	0.00152	CcSEcCtD
Eszopiclone—Alopecia—Epirubicin—liver cancer	0.000932	0.0015	CcSEcCtD
Eszopiclone—Erythema multiforme—Doxorubicin—liver cancer	0.000923	0.00148	CcSEcCtD
Eszopiclone—Tinnitus—Doxorubicin—liver cancer	0.00091	0.00146	CcSEcCtD
Eszopiclone—Tension—Epirubicin—liver cancer	0.000901	0.00145	CcSEcCtD
Eszopiclone—Dysgeusia—Epirubicin—liver cancer	0.000899	0.00144	CcSEcCtD
Eszopiclone—Nervousness—Epirubicin—liver cancer	0.000892	0.00143	CcSEcCtD
Eszopiclone—Back pain—Epirubicin—liver cancer	0.000888	0.00143	CcSEcCtD
Eszopiclone—Muscle spasms—Epirubicin—liver cancer	0.000883	0.00142	CcSEcCtD
Eszopiclone—Chills—Doxorubicin—liver cancer	0.000876	0.00141	CcSEcCtD
Eszopiclone—Vision blurred—Epirubicin—liver cancer	0.000866	0.00139	CcSEcCtD
Eszopiclone—Alopecia—Doxorubicin—liver cancer	0.000863	0.00138	CcSEcCtD
Eszopiclone—Ill-defined disorder—Epirubicin—liver cancer	0.000852	0.00137	CcSEcCtD
Eszopiclone—Anaemia—Epirubicin—liver cancer	0.000849	0.00136	CcSEcCtD
Eszopiclone—Agitation—Epirubicin—liver cancer	0.000844	0.00135	CcSEcCtD
Eszopiclone—Tension—Doxorubicin—liver cancer	0.000834	0.00134	CcSEcCtD
Eszopiclone—Dysgeusia—Doxorubicin—liver cancer	0.000832	0.00134	CcSEcCtD
Eszopiclone—Malaise—Epirubicin—liver cancer	0.000828	0.00133	CcSEcCtD
Eszopiclone—Nervousness—Doxorubicin—liver cancer	0.000825	0.00132	CcSEcCtD
Eszopiclone—Vertigo—Epirubicin—liver cancer	0.000825	0.00132	CcSEcCtD
Eszopiclone—Back pain—Doxorubicin—liver cancer	0.000822	0.00132	CcSEcCtD
Eszopiclone—Muscle spasms—Doxorubicin—liver cancer	0.000817	0.00131	CcSEcCtD
Eszopiclone—Palpitations—Epirubicin—liver cancer	0.000812	0.0013	CcSEcCtD
Eszopiclone—Vision blurred—Doxorubicin—liver cancer	0.000801	0.00128	CcSEcCtD
Eszopiclone—Convulsion—Epirubicin—liver cancer	0.000796	0.00128	CcSEcCtD
Eszopiclone—Hypertension—Epirubicin—liver cancer	0.000793	0.00127	CcSEcCtD
Eszopiclone—Ill-defined disorder—Doxorubicin—liver cancer	0.000788	0.00126	CcSEcCtD
Eszopiclone—Anaemia—Doxorubicin—liver cancer	0.000785	0.00126	CcSEcCtD
Eszopiclone—Chest pain—Epirubicin—liver cancer	0.000782	0.00125	CcSEcCtD
Eszopiclone—Myalgia—Epirubicin—liver cancer	0.000782	0.00125	CcSEcCtD
Eszopiclone—Agitation—Doxorubicin—liver cancer	0.000781	0.00125	CcSEcCtD
Eszopiclone—Anxiety—Epirubicin—liver cancer	0.000779	0.00125	CcSEcCtD
Eszopiclone—Discomfort—Epirubicin—liver cancer	0.000773	0.00124	CcSEcCtD
Eszopiclone—Malaise—Doxorubicin—liver cancer	0.000766	0.00123	CcSEcCtD
Eszopiclone—Dry mouth—Epirubicin—liver cancer	0.000765	0.00123	CcSEcCtD
Eszopiclone—Vertigo—Doxorubicin—liver cancer	0.000763	0.00122	CcSEcCtD
Eszopiclone—Confusional state—Epirubicin—liver cancer	0.000756	0.00121	CcSEcCtD
Eszopiclone—Palpitations—Doxorubicin—liver cancer	0.000751	0.0012	CcSEcCtD
Eszopiclone—Anaphylactic shock—Epirubicin—liver cancer	0.00075	0.0012	CcSEcCtD
Eszopiclone—Infection—Epirubicin—liver cancer	0.000745	0.00119	CcSEcCtD
Eszopiclone—Convulsion—Doxorubicin—liver cancer	0.000736	0.00118	CcSEcCtD
Eszopiclone—Hypertension—Doxorubicin—liver cancer	0.000734	0.00118	CcSEcCtD
Eszopiclone—Tachycardia—Epirubicin—liver cancer	0.000732	0.00117	CcSEcCtD
Eszopiclone—Hyperhidrosis—Epirubicin—liver cancer	0.000725	0.00116	CcSEcCtD
Eszopiclone—Chest pain—Doxorubicin—liver cancer	0.000723	0.00116	CcSEcCtD
Eszopiclone—Myalgia—Doxorubicin—liver cancer	0.000723	0.00116	CcSEcCtD
Eszopiclone—Anxiety—Doxorubicin—liver cancer	0.000721	0.00116	CcSEcCtD
Eszopiclone—Discomfort—Doxorubicin—liver cancer	0.000715	0.00115	CcSEcCtD
Eszopiclone—Anorexia—Epirubicin—liver cancer	0.000714	0.00115	CcSEcCtD
Eszopiclone—Dry mouth—Doxorubicin—liver cancer	0.000708	0.00114	CcSEcCtD
Eszopiclone—Confusional state—Doxorubicin—liver cancer	0.000699	0.00112	CcSEcCtD
Eszopiclone—Anaphylactic shock—Doxorubicin—liver cancer	0.000694	0.00111	CcSEcCtD
Eszopiclone—Infection—Doxorubicin—liver cancer	0.000689	0.00111	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000683	0.0011	CcSEcCtD
Eszopiclone—Insomnia—Epirubicin—liver cancer	0.000678	0.00109	CcSEcCtD
Eszopiclone—Tachycardia—Doxorubicin—liver cancer	0.000677	0.00109	CcSEcCtD
Eszopiclone—Paraesthesia—Epirubicin—liver cancer	0.000673	0.00108	CcSEcCtD
Eszopiclone—Hyperhidrosis—Doxorubicin—liver cancer	0.00067	0.00108	CcSEcCtD
Eszopiclone—Dyspnoea—Epirubicin—liver cancer	0.000668	0.00107	CcSEcCtD
Eszopiclone—Somnolence—Epirubicin—liver cancer	0.000666	0.00107	CcSEcCtD
Eszopiclone—Anorexia—Doxorubicin—liver cancer	0.000661	0.00106	CcSEcCtD
Eszopiclone—Dyspepsia—Epirubicin—liver cancer	0.00066	0.00106	CcSEcCtD
Eszopiclone—Decreased appetite—Epirubicin—liver cancer	0.000652	0.00105	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Epirubicin—liver cancer	0.000647	0.00104	CcSEcCtD
Eszopiclone—Fatigue—Epirubicin—liver cancer	0.000646	0.00104	CcSEcCtD
Eszopiclone—Constipation—Epirubicin—liver cancer	0.000641	0.00103	CcSEcCtD
Eszopiclone—Pain—Epirubicin—liver cancer	0.000641	0.00103	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000632	0.00101	CcSEcCtD
Eszopiclone—Insomnia—Doxorubicin—liver cancer	0.000627	0.00101	CcSEcCtD
Eszopiclone—Paraesthesia—Doxorubicin—liver cancer	0.000623	0.000999	CcSEcCtD
Eszopiclone—Dyspnoea—Doxorubicin—liver cancer	0.000618	0.000992	CcSEcCtD
Eszopiclone—Feeling abnormal—Epirubicin—liver cancer	0.000618	0.000991	CcSEcCtD
Eszopiclone—Somnolence—Doxorubicin—liver cancer	0.000617	0.000989	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Epirubicin—liver cancer	0.000613	0.000983	CcSEcCtD
Eszopiclone—Dyspepsia—Doxorubicin—liver cancer	0.00061	0.000979	CcSEcCtD
Eszopiclone—Decreased appetite—Doxorubicin—liver cancer	0.000603	0.000967	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000599	0.000961	CcSEcCtD
Eszopiclone—Fatigue—Doxorubicin—liver cancer	0.000598	0.000959	CcSEcCtD
Eszopiclone—Urticaria—Epirubicin—liver cancer	0.000595	0.000955	CcSEcCtD
Eszopiclone—Pain—Doxorubicin—liver cancer	0.000593	0.000951	CcSEcCtD
Eszopiclone—Constipation—Doxorubicin—liver cancer	0.000593	0.000951	CcSEcCtD
Eszopiclone—Body temperature increased—Epirubicin—liver cancer	0.000593	0.000951	CcSEcCtD
Eszopiclone—Abdominal pain—Epirubicin—liver cancer	0.000593	0.000951	CcSEcCtD
Eszopiclone—Feeling abnormal—Doxorubicin—liver cancer	0.000572	0.000917	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Doxorubicin—liver cancer	0.000567	0.00091	CcSEcCtD
Eszopiclone—Hypersensitivity—Epirubicin—liver cancer	0.000552	0.000886	CcSEcCtD
Eszopiclone—Urticaria—Doxorubicin—liver cancer	0.000551	0.000884	CcSEcCtD
Eszopiclone—Body temperature increased—Doxorubicin—liver cancer	0.000548	0.00088	CcSEcCtD
Eszopiclone—Abdominal pain—Doxorubicin—liver cancer	0.000548	0.00088	CcSEcCtD
Eszopiclone—Asthenia—Epirubicin—liver cancer	0.000538	0.000863	CcSEcCtD
Eszopiclone—Pruritus—Epirubicin—liver cancer	0.00053	0.000851	CcSEcCtD
Eszopiclone—Diarrhoea—Epirubicin—liver cancer	0.000513	0.000823	CcSEcCtD
Eszopiclone—Hypersensitivity—Doxorubicin—liver cancer	0.000511	0.00082	CcSEcCtD
Eszopiclone—Asthenia—Doxorubicin—liver cancer	0.000498	0.000798	CcSEcCtD
Eszopiclone—Dizziness—Epirubicin—liver cancer	0.000496	0.000795	CcSEcCtD
Eszopiclone—Pruritus—Doxorubicin—liver cancer	0.000491	0.000787	CcSEcCtD
Eszopiclone—Vomiting—Epirubicin—liver cancer	0.000477	0.000765	CcSEcCtD
Eszopiclone—Diarrhoea—Doxorubicin—liver cancer	0.000475	0.000761	CcSEcCtD
Eszopiclone—Rash—Epirubicin—liver cancer	0.000473	0.000758	CcSEcCtD
Eszopiclone—Dermatitis—Epirubicin—liver cancer	0.000472	0.000757	CcSEcCtD
Eszopiclone—Headache—Epirubicin—liver cancer	0.00047	0.000753	CcSEcCtD
Eszopiclone—Dizziness—Doxorubicin—liver cancer	0.000459	0.000736	CcSEcCtD
Eszopiclone—Nausea—Epirubicin—liver cancer	0.000445	0.000714	CcSEcCtD
Eszopiclone—Vomiting—Doxorubicin—liver cancer	0.000441	0.000707	CcSEcCtD
Eszopiclone—Rash—Doxorubicin—liver cancer	0.000437	0.000702	CcSEcCtD
Eszopiclone—Dermatitis—Doxorubicin—liver cancer	0.000437	0.000701	CcSEcCtD
Eszopiclone—Headache—Doxorubicin—liver cancer	0.000434	0.000697	CcSEcCtD
Eszopiclone—Nausea—Doxorubicin—liver cancer	0.000412	0.000661	CcSEcCtD
Eszopiclone—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000211	0.000648	CbGpPWpGaD
Eszopiclone—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000208	0.000639	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—RAF1—liver cancer	0.000208	0.000638	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000208	0.000637	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—GSTP1—liver cancer	0.000205	0.00063	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	0.000203	0.000621	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000202	0.000618	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—RAF1—liver cancer	0.000199	0.000612	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000197	0.000606	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—RAF1—liver cancer	0.000194	0.000594	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000193	0.000593	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000192	0.000588	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—BRAF—liver cancer	0.000191	0.000586	CbGpPWpGaD
Eszopiclone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000191	0.000585	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—RAF1—liver cancer	0.00019	0.000584	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—PPARA—liver cancer	0.00019	0.000581	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—GSTM1—liver cancer	0.000189	0.000579	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—IL6—liver cancer	0.000189	0.000578	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000188	0.000578	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—RAF1—liver cancer	0.000187	0.000573	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	0.000186	0.000571	CbGpPWpGaD
Eszopiclone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000185	0.000568	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000185	0.000568	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—RAF1—liver cancer	0.000182	0.000559	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000182	0.000558	CbGpPWpGaD
Eszopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000182	0.000558	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000182	0.000557	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000181	0.000554	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—CYP1A1—liver cancer	0.000179	0.000549	CbGpPWpGaD
Eszopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000179	0.000548	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	0.000177	0.000541	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000176	0.000538	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—PPARA—liver cancer	0.000174	0.000535	CbGpPWpGaD
Eszopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000174	0.000535	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—HRAS—liver cancer	0.00017	0.000522	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000167	0.000512	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—TNF—liver cancer	0.000166	0.000508	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000165	0.000506	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—UGDH—liver cancer	0.000164	0.000504	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000164	0.000504	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000162	0.000497	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—PPARA—liver cancer	0.00016	0.000489	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—RAF1—liver cancer	0.000159	0.000489	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000158	0.000484	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—HRAS—liver cancer	0.000157	0.000481	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—PPARA—liver cancer	0.000155	0.000475	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—EPT1—liver cancer	0.000155	0.000474	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CPT1B—liver cancer	0.000154	0.000473	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GLUL—liver cancer	0.000154	0.000473	CbGpPWpGaD
Eszopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000152	0.000467	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—PPARA—liver cancer	0.000152	0.000467	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000151	0.000463	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—PPARA—liver cancer	0.00015	0.000459	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NR1H4—liver cancer	0.000149	0.000456	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—TAT—liver cancer	0.000147	0.00045	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTA3—liver cancer	0.000146	0.000448	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—PPARA—liver cancer	0.000146	0.000448	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000144	0.000442	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—HRAS—liver cancer	0.000143	0.00044	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—ALB—liver cancer	0.000141	0.000432	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—HRAS—liver cancer	0.000139	0.000427	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—HRAS—liver cancer	0.000137	0.000419	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000135	0.000415	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—HRAS—liver cancer	0.000134	0.000412	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000134	0.000412	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—UGDH—liver cancer	0.000134	0.00041	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—IL6—liver cancer	0.000134	0.00041	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTA4—liver cancer	0.000134	0.00041	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000134	0.00041	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—HRAS—liver cancer	0.000131	0.000402	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000131	0.000401	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—HRAS—liver cancer	0.00013	0.0004	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTA2—liver cancer	0.00013	0.0004	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—ALB—liver cancer	0.00013	0.000398	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000128	0.000391	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—RAF1—liver cancer	0.000127	0.000391	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—EPT1—liver cancer	0.000126	0.000386	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTA1—liver cancer	0.000126	0.000386	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000124	0.000382	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NAT2—liver cancer	0.000124	0.000381	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000123	0.000377	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—HRAS—liver cancer	0.00012	0.000368	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.00012	0.000367	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—TAT—liver cancer	0.000119	0.000366	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ALDOB—liver cancer	0.000119	0.000366	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—ALB—liver cancer	0.000119	0.000364	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000118	0.000362	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000117	0.00036	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—RAF1—liver cancer	0.000117	0.00036	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000116	0.000357	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—ALB—liver cancer	0.000115	0.000353	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—HRAS—liver cancer	0.000115	0.000351	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CRABP1—liver cancer	0.000114	0.000349	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—ALB—liver cancer	0.000113	0.000347	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—ALB—liver cancer	0.000111	0.000341	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—HRAS—liver cancer	0.00011	0.000337	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—ALB—liver cancer	0.000108	0.000333	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000108	0.000331	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000107	0.000329	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—HRAS—liver cancer	0.000107	0.000327	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—HRAS—liver cancer	0.000105	0.000321	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—RAF1—liver cancer	0.000104	0.000319	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—HRAS—liver cancer	0.000103	0.000316	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000102	0.000314	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—RAF1—liver cancer	0.000102	0.000314	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000101	0.000308	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—HRAS—liver cancer	0.0001	0.000308	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GLUL—liver cancer	9.96e-05	0.000306	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CPT1B—liver cancer	9.96e-05	0.000306	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—HPGDS—liver cancer	9.94e-05	0.000305	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.88e-05	0.000303	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—RAF1—liver cancer	9.81e-05	0.000301	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NR1H4—liver cancer	9.61e-05	0.000295	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—ALB—liver cancer	9.48e-05	0.000291	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTA3—liver cancer	9.45e-05	0.00029	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	9e-05	0.000276	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.89e-05	0.000273	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PSMD10—liver cancer	8.86e-05	0.000272	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PSMA4—liver cancer	8.86e-05	0.000272	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—UGDH—liver cancer	8.83e-05	0.000271	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	8.78e-05	0.000269	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—HRAS—liver cancer	8.78e-05	0.000269	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTA4—liver cancer	8.64e-05	0.000265	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GOT2—liver cancer	8.62e-05	0.000264	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—RAF1—liver cancer	8.57e-05	0.000263	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	8.44e-05	0.000259	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTA2—liver cancer	8.42e-05	0.000258	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—EPT1—liver cancer	8.3e-05	0.000255	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTA1—liver cancer	8.12e-05	0.000249	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CPT1B—liver cancer	8.11e-05	0.000249	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GLUL—liver cancer	8.11e-05	0.000249	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP2E1—liver cancer	8.1e-05	0.000249	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NAT2—liver cancer	8.03e-05	0.000246	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—TAT—liver cancer	7.87e-05	0.000241	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.85e-05	0.000241	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NR1H4—liver cancer	7.82e-05	0.00024	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	7.72e-05	0.000237	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ALDOB—liver cancer	7.7e-05	0.000236	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTA3—liver cancer	7.69e-05	0.000236	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYCS—liver cancer	7.58e-05	0.000233	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GGT1—liver cancer	7.44e-05	0.000228	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GOT1—liver cancer	7.44e-05	0.000228	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CRABP1—liver cancer	7.35e-05	0.000225	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTA4—liver cancer	7.03e-05	0.000216	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	6.87e-05	0.000211	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTA2—liver cancer	6.85e-05	0.00021	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTP1—liver cancer	6.68e-05	0.000205	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	6.61e-05	0.000203	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTA1—liver cancer	6.61e-05	0.000203	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—HMOX1—liver cancer	6.59e-05	0.000202	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NAT2—liver cancer	6.54e-05	0.0002	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—HPGDS—liver cancer	6.42e-05	0.000197	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	6.38e-05	0.000196	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	6.29e-05	0.000193	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ALDOB—liver cancer	6.27e-05	0.000192	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTM1—liver cancer	6.14e-05	0.000188	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CRABP1—liver cancer	5.98e-05	0.000183	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP1A1—liver cancer	5.82e-05	0.000179	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.81e-05	0.000178	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.74e-05	0.000176	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PSMA4—liver cancer	5.72e-05	0.000176	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PSMD10—liver cancer	5.72e-05	0.000176	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GOT2—liver cancer	5.57e-05	0.000171	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—MTHFR—liver cancer	5.43e-05	0.000166	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.38e-05	0.000165	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CPT1B—liver cancer	5.35e-05	0.000164	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GLUL—liver cancer	5.35e-05	0.000164	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PPARA—liver cancer	5.32e-05	0.000163	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP2E1—liver cancer	5.23e-05	0.000161	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—HPGDS—liver cancer	5.23e-05	0.00016	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.2e-05	0.000159	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NR1H4—liver cancer	5.16e-05	0.000158	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTA3—liver cancer	5.07e-05	0.000155	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.07e-05	0.000155	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYCS—liver cancer	4.9e-05	0.00015	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GOT1—liver cancer	4.81e-05	0.000147	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GGT1—liver cancer	4.81e-05	0.000147	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.78e-05	0.000147	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.73e-05	0.000145	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.67e-05	0.000143	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PSMD10—liver cancer	4.66e-05	0.000143	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PSMA4—liver cancer	4.66e-05	0.000143	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTA4—liver cancer	4.64e-05	0.000142	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CG—liver cancer	4.56e-05	0.00014	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GOT2—liver cancer	4.53e-05	0.000139	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTA2—liver cancer	4.52e-05	0.000139	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PPARG—liver cancer	4.4e-05	0.000135	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTA1—liver cancer	4.36e-05	0.000134	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTP1—liver cancer	4.32e-05	0.000132	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NAT2—liver cancer	4.31e-05	0.000132	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP2E1—liver cancer	4.26e-05	0.000131	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—HMOX1—liver cancer	4.26e-05	0.000131	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ALDOB—liver cancer	4.13e-05	0.000127	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.12e-05	0.000126	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CD—liver cancer	4.01e-05	0.000123	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYCS—liver cancer	3.99e-05	0.000122	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTM1—liver cancer	3.97e-05	0.000122	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ALB—liver cancer	3.96e-05	0.000121	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CRABP1—liver cancer	3.94e-05	0.000121	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GOT1—liver cancer	3.91e-05	0.00012	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GGT1—liver cancer	3.91e-05	0.00012	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP1A1—liver cancer	3.76e-05	0.000115	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTP1—liver cancer	3.51e-05	0.000108	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—MTHFR—liver cancer	3.51e-05	0.000108	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CB—liver cancer	3.49e-05	0.000107	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—HMOX1—liver cancer	3.46e-05	0.000106	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HPGDS—liver cancer	3.45e-05	0.000106	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PPARA—liver cancer	3.44e-05	0.000105	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTM1—liver cancer	3.23e-05	9.9e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.09e-05	9.47e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PSMA4—liver cancer	3.07e-05	9.42e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PSMD10—liver cancer	3.07e-05	9.42e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP1A1—liver cancer	3.06e-05	9.39e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GOT2—liver cancer	2.99e-05	9.16e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CG—liver cancer	2.95e-05	9.03e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—MTHFR—liver cancer	2.85e-05	8.75e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PPARG—liver cancer	2.84e-05	8.72e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP2E1—liver cancer	2.81e-05	8.62e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PPARA—liver cancer	2.8e-05	8.58e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYCS—liver cancer	2.63e-05	8.06e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CD—liver cancer	2.59e-05	7.94e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GGT1—liver cancer	2.58e-05	7.91e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GOT1—liver cancer	2.58e-05	7.91e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ALB—liver cancer	2.56e-05	7.84e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.51e-05	7.71e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CG—liver cancer	2.4e-05	7.35e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTP1—liver cancer	2.32e-05	7.11e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PPARG—liver cancer	2.31e-05	7.1e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HMOX1—liver cancer	2.28e-05	7.01e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CB—liver cancer	2.26e-05	6.92e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CA—liver cancer	2.13e-05	6.53e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTM1—liver cancer	2.13e-05	6.53e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CD—liver cancer	2.11e-05	6.46e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ALB—liver cancer	2.08e-05	6.38e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP1A1—liver cancer	2.02e-05	6.19e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—MTHFR—liver cancer	1.88e-05	5.77e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PPARA—liver cancer	1.85e-05	5.66e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CB—liver cancer	1.84e-05	5.63e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—AKT1—liver cancer	1.74e-05	5.34e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CG—liver cancer	1.58e-05	4.85e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PPARG—liver cancer	1.53e-05	4.68e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CD—liver cancer	1.39e-05	4.26e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CA—liver cancer	1.38e-05	4.22e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ALB—liver cancer	1.37e-05	4.21e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CB—liver cancer	1.21e-05	3.72e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—AKT1—liver cancer	1.12e-05	3.45e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CA—liver cancer	1.12e-05	3.43e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—AKT1—liver cancer	9.15e-06	2.81e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CA—liver cancer	7.38e-06	2.26e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—AKT1—liver cancer	6.03e-06	1.85e-05	CbGpPWpGaD
